Table 2 from Novel Pretreatment Autoantibodies Correlate with Enfortumab Vedotin–Related Dermatologic Events in Patients with Advanced Urothelial Cancer
<p>Autoantibody presence at baseline in patients in cohorts A (<i>n</i> = 6) and B (<i>n</i> = 23) with vs. without EVDEs and in patients with EVDEs requiring intervention.</p>
Authors
- Noah M. Hahn (ORCID: https://orcid.org/0000-0002-1016-9024)
- Livia Casciola‐Rosen (ORCID: https://orcid.org/0000-0002-4172-1539)
- Antony Rosen (ORCID: https://orcid.org/0000-0002-8374-4763)
- Jean Hoffman‐Censits (ORCID: https://orcid.org/0000-0002-6970-6509)
- Burles A. Johnson (ORCID: https://orcid.org/0000-0002-7180-8790)
- David J. McConkey (ORCID: https://orcid.org/0000-0003-1971-0638)
- Evangelia Vlachou (ORCID: https://orcid.org/0009-0007-5486-2983)
- Stephanie Russell
- Yuezhou Jing (ORCID: https://orcid.org/0000-0002-4597-7064)
- Daniel Stairiker
Publication Details
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1158/2767-9764.30154386
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00